Literature DB >> 31020641

Establishment and characterization of a prostate cancer cell line from a prostatectomy specimen for the study of cellular interaction.

Ruoxiang Wang1, Gina C-Y Chu1, Xudong Wang1, Jason B Wu1, Peizhen Hu1, Asha S Multani2, Sen Pathak2, Haiyen E Zhau1, Leland W K Chung1.   

Abstract

Though human prostate cancer (PCa) heterogeneity can best be studied using multiple cell types isolated from clinical specimens, the difficulty of establishing cell lines from clinical tumors has hampered this approach. In this proof-of-concept study, we established a human PCa cell line from a prostatectomy surgical specimen without the need for retroviral transduction. In a previous report, we characterized the stromal cells derived from PCa specimens. Here, we characterized the epithelial cells isolated from the same tumors. Compared to the ease of establishing prostate stromal cell lines, prostatic epithelial cell lines are challenging. From three matched pairs of normal and tumor tissues, we established one new PCa cell line, HPE-15. We confirmed the origin of HPE-15 cells by short tandem repeat microsatellite polymorphism analysis. HPE-15 cells are androgen-insensitive and express marginal androgen receptor, prostate-specific antigen and prostate-specific membrane antigen proteins. HPE-15 expresses luminal epithelial markers of E-cadherin and cytokeratin 18, basal cell markers of cytokeratin 5 and p63 and neuroendocrine marker of chromogranin A. Interestingly, HPE-15 Cells exhibited no tumorigenicity in different strains of immune-deficient mice but can become tumorigenic through interaction with aggressive cancer cell types. HPE-15 cells can thus serve as an experimental model for the study of PCa progression, metastasis and tumor cell dormancy.
© 2019 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Entities:  

Keywords:  and cell-cell interaction; cell line; prostate cancer; transit amplifying

Mesh:

Substances:

Year:  2019        PMID: 31020641      PMCID: PMC6703920          DOI: 10.1002/ijc.32370

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  42 in total

Review 1.  Anoikis: a necessary death program for anchorage-dependent cells.

Authors:  Paola Chiarugi; Elisa Giannoni
Journal:  Biochem Pharmacol       Date:  2008-07-25       Impact factor: 5.858

Review 2.  Live free or die: tales of homeless (cells) in cancer.

Authors:  Craig Horbinski; Colton Mojesky; Natasha Kyprianou
Journal:  Am J Pathol       Date:  2010-07-16       Impact factor: 4.307

3.  hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis.

Authors:  Ira Kogan; Naomi Goldfinger; Michael Milyavsky; Merav Cohen; Igor Shats; Gabriele Dobler; Helmut Klocker; Bohdan Wasylyk; Maureen Voller; Tilly Aalders; Jack A Schalken; Moshe Oren; Varda Rotter
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

4.  Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice.

Authors:  A Taghian; W Budach; A Zietman; J Freeman; D Gioioso; W Ruka; H D Suit
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

5.  Strain- and age-dependent natural and activated in vitro cytotoxicity in athymic nude mice.

Authors:  C Radzikowski; J Rygaard; W Budzynski; J P Stenvang; M Schou; A Vangsted; J Zeuthen
Journal:  APMIS       Date:  1994-07       Impact factor: 3.205

6.  LNCaP model of human prostatic carcinoma.

Authors:  J S Horoszewicz; S S Leong; E Kawinski; J P Karr; H Rosenthal; T M Chu; E A Mirand; G P Murphy
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

Review 7.  Cells of origin for cancer: an updated view from prostate cancer.

Authors:  L Xin
Journal:  Oncogene       Date:  2012-11-26       Impact factor: 9.867

8.  Progressive epithelial to mesenchymal transitions in ARCaP E prostate cancer cells during xenograft tumor formation and metastasis.

Authors:  Hui He; Xiaojian Yang; Alec J Davidson; Daqing Wu; Fray F Marshall; Leland W K Chung; Haiyen E Zhau; Ruoxiang Wang
Journal:  Prostate       Date:  2010-04-01       Impact factor: 4.104

9.  Physiological normal levels of androgen inhibit proliferation of prostate cancer cells in vitro.

Authors:  Weitao Song; Mohit Khera
Journal:  Asian J Androl       Date:  2014 Nov-Dec       Impact factor: 3.285

10.  Spontaneous cancer-stromal cell fusion as a mechanism of prostate cancer androgen-independent progression.

Authors:  Ruoxiang Wang; Xiaojuan Sun; Christopher Y Wang; Peizhen Hu; Chia-Yi Chu; Shurong Liu; Haiyen E Zhau; Leland W K Chung
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

View more
  4 in total

1.  Cancer-stromal cell fusion as revealed by fluorescence protein tracking.

Authors:  Ruoxiang Wang; Michael S Lewis; Ji Lyu; Haiyen E Zhau; Stephen J Pandol; Leland W K Chung
Journal:  Prostate       Date:  2019-12-17       Impact factor: 4.104

Review 2.  Role of prostate and bone stromal cells on prostate cancer progression.

Authors:  Sofia Karkampouna; Marianna Kruithof-de Julio; George N Thalmann
Journal:  Am J Clin Exp Urol       Date:  2022-06-15

3.  Circulating Fatty Objects and Their Preferential Presence in Pancreatic Cancer Patient Blood Samples.

Authors:  Ruoxiang Wang; Nicholas N Nissen; Yi Zhang; Chen Shao; Chia-Yi Chu; Carissa Huynh; Edwin M Posadas; James S Tomlinson; Michael S Lewis; Stephen J Pandol
Journal:  Front Physiol       Date:  2022-02-14       Impact factor: 4.566

4.  Establishment and characterization of a new human colon cancer cell line, PUMC-CRC1.

Authors:  Xiaocui Bian; Fang Cao; Xiaowan Wang; Yuhong Hou; Haitao Zhao; Yuqin Liu
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.